Home / Business and Economy / Kimball Solutions Misses Earnings, Eyes Medical Growth
Kimball Solutions Misses Earnings, Eyes Medical Growth
17 Aug
Summary
- Q2 CY2026 revenue of $371.6 million fell 2.3% year-on-year.
- Adjusted EPS of -$0.01 significantly missed analyst estimates of $0.39.
- Full-year revenue guidance of $1.55 billion exceeded analyst expectations.
In the second quarter of CY2026, Kimball Solutions reported revenue of $371.6 million, marking a 2.3% decline from the previous year and narrowly missing analyst expectations. The company's adjusted earnings per share also fell short, coming in at -$0.01 against an estimated $0.39. Despite these challenges, Kimball Solutions reaffirmed its full-year revenue forecast at $1.55 billion, slightly surpassing analyst predictions.
Management attributed the quarter's performance to robust execution within the Medical sector, which demonstrated continued growth and compensated for weaker results in the Automotive and Industrial segments. CEO Richard Phillips noted an "broad-based improvement" in medical device demand. The company also achieved its lowest debt level in over four years and benefited from more balanced geographical sales distribution.
Looking ahead, Kimball Solutions anticipates significant contributions from its expanding Medical segment, projected to reach 35% of total sales, and the recent acquisition of Helvoet Polymer Technologies. However, the ramp-up of a new medical facility in Indianapolis is expected to generate revenue starting in the fourth quarter of CY2026, with full production taking time. The company plans to balance growth investments with share repurchases and leverage management.
